Edwards Lifesciences Corporation EW

Set alert

Price alert · EW

All alert types
93.26 USD +1.25 +1.36%

At close

93.10 -0.16 -0.17%

Pre-market · Nov 3, 7:35 AM ET

Bid
93.23 × 200
Ask
93.27 × 200
87.93 Day range 95.75
74.66 52-week range 96.29
YTD
+9.40%
1 year
+12.27%
Open
93.16
Prev close
92.01
Mkt cap
53.70B
Vol
12.17M
Avg vol
3.47M
EPS
1.68
P/E
55.51
Div yield
0.00%
More statistics
Low
87.93
High
95.75
Forward P/E
27.58
Beta
0.83
Short ratio
2.43
Inst. own
95.48%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
88.14
200-d avg
85.43
1y target
101.87

5D chart

Chart tools
Interval

Signals (129)
NameTimeAgo
SMA: BullishNov 2, 3:15 PM17 hours ago
SMA: BearishNov 2, 3:10 PM17 hours ago
SMA: BullishNov 2, 3:05 PM17 hours ago
SMA: BearishNov 2, 2:45 PM17 hours ago
SMA: BullishNov 2, 2:25 PM17 hours ago
SMA: BullishNov 2, 2:25 PM17 hours ago
SMA: BearishNov 2, 2:10 PM18 hours ago
MACD: Buy SignalNov 2, 1:30 PM18 hours ago
SMA: BullishNov 2, 1:20 PM19 hours ago
RSI: OversoldNov 2, 12:45 PM19 hours ago
SMA: BearishNov 2, 12:40 PM19 hours ago
SMA: BearishNov 2, 12:40 PM19 hours ago
SMA: BullishNov 2, 12:35 PM19 hours ago
SMA: BullishNov 2, 12:35 PM19 hours ago
SMA: BearishNov 2, 12:30 PM19 hours ago
SMA: BearishNov 2, 12:10 PM20 hours ago
SMA: BullishNov 2, 12:00 PM20 hours ago
SMA: BearishNov 2, 11:55 AM20 hours ago
MACD: Sell SignalNov 2, 11:50 AM20 hours ago
MACD: Buy SignalNov 2, 11:30 AM20 hours ago

Newest 20 of 129.

Analyst view

Consensus: buy

Buy
Price target (mean) 101.87 +9.2% upside
Target (low)
84.00
Target (mean)
101.87
Target (high)
117.00
Ratings (0m) 30 23 buy · 7 hold · 0 sell
  • Strong buy5
  • Buy18
  • Hold7
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 30
  • 1 month ago 29
  • 2 months ago 29

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

EW analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.736530.72 – 0.770.67+9.9%1.68B+8.0%24
Next quarter0.70640.67 – 0.76260.58+21.8%1.70B+8.3%24
Current year3.002.96 – 3.052.56+17.2%6.76B+11.4%29
Next year3.383.29 – 3.503.00+12.7%7.43B+9.9%29

Upgrades and downgrades

The latest rating changes

EW analyst upgrades and downgrades
DateFirmActionFromTo
Oct 7, 2026BarclaysInitiated—Overweight
Sep 11, 2026BTIGReiteratedBuyBuy
Jul 24, 2026Leerink PartnersUpgradeMarket PerformOutperform
Jul 24, 2026JP MorganMaintainedOverweightOverweight
Jul 24, 2026Piper SandlerReiteratedOverweightOverweight
Jul 16, 2026Truist SecuritiesMaintainedHoldHold
Jul 15, 2026MizuhoMaintainedOutperformOutperform
Jul 13, 2026RBC CapitalMaintainedOutperformOutperform
Jul 8, 2026CitigroupMaintainedBuyBuy
Jul 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Jun 30, 2026BTIGMaintainedBuyBuy
Jun 16, 2026RBC CapitalReiteratedOutperformOutperform
Jun 2, 2026TD CowenMaintainedBuyBuy
Apr 27, 2026BarclaysMaintainedOverweightOverweight
Apr 24, 2026Evercore ISI GroupMaintainedOutperformOutperform
Apr 24, 2026Truist SecuritiesMaintainedHoldHold
Apr 24, 2026Canaccord GenuityMaintainedHoldHold
Apr 24, 2026BTIGMaintainedBuyBuy
Apr 24, 2026BairdMaintainedNeutralNeutral
Apr 13, 2026MizuhoMaintainedOutperformOutperform
Apr 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Feb 11, 2026Goldman SachsMaintainedBuyBuy
Feb 11, 2026Piper SandlerReiteratedOverweightOverweight
Feb 11, 2026Truist SecuritiesMaintainedHoldHold
Feb 11, 2026Wells FargoMaintainedOverweightOverweight
Feb 11, 2026BTIGReiteratedBuyBuy
Jan 20, 2026StifelMaintainedBuyBuy
Jan 20, 2026Piper SandlerMaintainedOverweightOverweight
Jan 12, 2026UBSMaintainedNeutralNeutral
Jan 12, 2026BarclaysMaintainedOverweightOverweight